Murali V.P. Nadella
Biogen (United States)(US)
Publications by Year
Research Areas
T-cell and Retrovirus Studies, Virus-based gene therapy research, Bone health and treatments, Prostate Cancer Treatment and Research, Cytokine Signaling Pathways and Interactions
Most-Cited Works
- → AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer(2015)433 cited
- → STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial(2018)282 cited
- → New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft(2006)73 cited
- → A novel canine lymphoma cell line: A translational and comparative model for lymphoma research(2007)50 cited
- → Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions(2008)48 cited
- → Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases(2007)47 cited
- → Discovery of (+)-N-(3-Aminopropyl)-N-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide (AZD4877), a Kinesin Spindle Protein Inhibitor and Potential Anticancer Agent(2011)43 cited
- → Development of a brain metastatic canine prostate cancer cell line(2011)41 cited
- → Comparisons of the Efficacy of a Jak1/2 Inhibitor (AZD1480) with a VEGF Signaling Inhibitor (Cediranib) and Sham Treatments in Mouse Tumors Using DCE-MRI, DW-MRI, and Histology(2012)38 cited
- → A Novel Bioluminescent Mouse Model and Effective Therapy for Adult T-Cell Leukemia/Lymphoma(2007)32 cited